Header cover image

Taiwanese (TAIEX) Life Sciences Industry Analysis

UpdatedApr 22, 2024
DataAggregated Company Financials
Companies9
  • 7D-6.7%
  • 3M-14.5%
  • 1Y-29.5%
  • YTD-19.0%

Over the last 7 days, the Life Sciences industry has dropped 4.3%, driven by a pullback from EirGenix of 9.7%. Overall the industry is down 30% in 12 months. Looking forward, earnings are forecast to grow by 147% annually.

Industry Valuation and Performance

Has the Taiwanese Life Sciences Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 22 Apr 2024NT$38.2bNT$2.1b-NT$923,759,000.0030x-41.4x18.1x
Wed, 20 Mar 2024NT$40.4bNT$2.1b-NT$611,433,000.0032.1x-66.1x19.6x
Fri, 16 Feb 2024NT$43.3bNT$2.1b-NT$610,218,000.0032.5x-71x20.9x
Sun, 14 Jan 2024NT$44.9bNT$2.1b-NT$610,218,000.0033.3x-73.6x21.6x
Tue, 12 Dec 2023NT$48.7bNT$2.1b-NT$610,218,000.0033.4x-79.9x23.5x
Thu, 09 Nov 2023NT$49.3bNT$2.2b-NT$497,769,000.0032.3x-99.1x22.2x
Sat, 07 Oct 2023NT$48.3bNT$2.2b-NT$497,769,000.0031.4x-97.1x21.7x
Mon, 04 Sep 2023NT$43.9bNT$2.2b-NT$497,769,000.0031.8x-88.2x19.7x
Wed, 02 Aug 2023NT$48.4bNT$2.5b-NT$274,767,000.0043x-176.3x19.8x
Fri, 30 Jun 2023NT$51.0bNT$2.5b-NT$274,767,000.0043.2x-185.7x20.8x
Sun, 28 May 2023NT$50.0bNT$2.5b-NT$262,467,000.0043.4x-190.4x20.2x
Tue, 25 Apr 2023NT$47.4bNT$2.7b-NT$29,761,000.0023.6x-1591.1x17.8x
Thu, 23 Mar 2023NT$48.7bNT$2.6b-NT$28,959,000.0024.1x-1680.2x18.4x
Sat, 18 Feb 2023NT$51.0bNT$2.7bNT$85.3m19.7x598x19.1x
Mon, 16 Jan 2023NT$45.2bNT$2.7bNT$85.3m18.9x529.9x16.9x
Wed, 14 Dec 2022NT$56.5bNT$2.7bNT$139.5m18.9x405.4x21.1x
Fri, 11 Nov 2022NT$43.1bNT$3.0bNT$480.6m23.4x89.7x14.4x
Sun, 09 Oct 2022NT$46.8bNT$3.0bNT$482.8m24.6x97x15.6x
Tue, 06 Sep 2022NT$53.8bNT$3.0bNT$482.8m28.2x111.5x18x
Thu, 04 Aug 2022NT$39.4bNT$3.1bNT$325.1m37.6x121.3x12.9x
Sat, 02 Jul 2022NT$40.6bNT$3.1bNT$325.1m36.8x124.8x13.2x
Mon, 30 May 2022NT$30.1bNT$3.1bNT$325.1m35.4x92.5x9.8x
Wed, 27 Apr 2022NT$35.0bNT$3.2bNT$164.4m28.3x213.1x11x
Fri, 25 Mar 2022NT$33.1bNT$3.0b-NT$134,053,000.0027.1x-247x11x
Sun, 20 Feb 2022NT$36.2bNT$3.0b-NT$120,147,000.0035.5x-301.2x11.9x
Tue, 18 Jan 2022NT$38.5bNT$3.0b-NT$120,147,000.0034.7x-320x12.6x
Thu, 16 Dec 2021NT$38.6bNT$3.0b-NT$120,147,000.0037.2x-321.4x12.7x
Sat, 13 Nov 2021NT$30.1bNT$2.8b-NT$512,667,000.0023.1x-58.8x10.8x
Mon, 11 Oct 2021NT$30.8bNT$2.3b-NT$631,150,000.0031.8x-48.8x13.2x
Wed, 08 Sep 2021NT$35.4bNT$2.3b-NT$631,150,000.0032.1x-56.1x15.2x
Fri, 06 Aug 2021NT$39.4bNT$2.3b-NT$631,150,000.0032.4x-62.4x16.9x
Mon, 10 May 2021NT$33.9bNT$2.2b-NT$810,177,000.0029.2x-41.8x15.6x
Price to Earnings Ratio

-41.8x


Total Market Cap: NT$33.9bTotal Earnings: -NT$810,177,000.00Total Revenue: NT$2.2bTotal Market Cap vs Earnings and Revenue0%0%0%
Taiwanese Life Sciences Industry Price to Earnings3Y Average -90.3x202220232024
Current Industry PE
  • Investors are optimistic on the Taiwanese Life Sciences industry, and appear confident in long term growth rates.
  • The 3-year average PS ratio of 16.7x is lower than the industry's current PS ratio of 18.6x.
Past Earnings Growth
  • The earnings for companies in the Life Sciences industry have deteriorated over the last three years.
  • Meanwhile revenues have remained mostly flat.
  • This means that although sales have remained flat, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.

Industry Trends

Which industries have driven the changes within the Taiwanese Healthcare industry?

TW Market-5.75%
Healthcare-6.66%
Life Sciences-6.66%
Clinical Research and Equipment-6.66%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
7607 DuoGenic StemCellsNT$33.104.7%
+NT$45.8m
n/an/a
6662 BioLASCO TaiwanNT$35.452.8%
+NT$24.3m
18.0%PE18.3x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

6891

NT$28.00

Locus Cell

7D

-1.8%

1Y

-38.2%

6848

NT$15.65

RBC Bioscience

7D

-1.6%

1Y

-13.5%

6939

NT$41.50

TFBS Bioscience

7D

-3.4%

1Y

n/a

6986

NT$67.90

HeXun Biosciences

7D

-3.7%

1Y

n/a

6589

NT$77.00

EirGenix

7D

-6.4%

1Y

-29.7%

6662

NT$35.45

BioLASCO Taiwan

7D

2.8%

1Y

18.0%

6661

NT$22.25

Welgene BiotechLtd

7D

-0.7%

1Y

-1.1%

4133

NT$30.15

Abnova (Taiwan)

7D

-3.2%

1Y

-15.8%

7607

NT$33.10

DuoGenic StemCells

7D

4.7%

1Y

n/a